These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 1846311)

  • 21. The regulation of the activation of the fibrinolysis system.
    Takada A; Urano T; Takada Y
    Adv Exp Med Biol; 1990; 281():209-22. PubMed ID: 2129370
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinolysis and host response in bacterial infections.
    Bergmann S; Hammerschmidt S
    Thromb Haemost; 2007 Sep; 98(3):512-20. PubMed ID: 17849039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possibilities of intervention in intrinsic and extrinsic lysis programs.
    Lowe GD
    Ann N Y Acad Sci; 1992 Dec; 667():272-7. PubMed ID: 1309044
    [No Abstract]   [Full Text] [Related]  

  • 24. Components of the plasminogen-plasmin system in human tumor cell lines.
    Kwaan HC; Keer HN; Radosevich JA; Cajot JF; Ernst R
    Semin Thromb Hemost; 1991 Jul; 17(3):175-82. PubMed ID: 1839079
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibrinolysis and cancer.
    Kwaan HC; Keer HN
    Semin Thromb Hemost; 1990 Jul; 16(3):230-5. PubMed ID: 2146746
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of the pericellular activation of plasminogen and its role in tissue-destructive processes.
    Vaheri A; Bizik J; Salonen EM; Tapiovaara H; Sirén V; Myöhänen H; Stephens RW
    Acta Ophthalmol Suppl (1985); 1992; (202):34-41. PubMed ID: 1322009
    [No Abstract]   [Full Text] [Related]  

  • 27. Occurrence of components of fibrinolysis pathways in situ in neoplastic and nonneoplastic human breast tissue.
    Costantini V; Zacharski LR; Memoli VA; Kudryk BJ; Rousseau SM; Stump DC
    Cancer Res; 1991 Jan; 51(1):354-8. PubMed ID: 1846311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activation system of the platelets.
    Park S
    Rinsho Byori; 1992 Mar; Suppl 92():131-43. PubMed ID: 1583771
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recent progress in fibrinolytic mechanism].
    Yasukouchi T
    Rinsho Byori; 1986 Mar; 34(3):235-46. PubMed ID: 3086600
    [No Abstract]   [Full Text] [Related]  

  • 30. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways of coagulation/fibrinolysis activation in malignancy.
    Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
    Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo.
    Krishnamurti C; Alving BM
    Semin Thromb Hemost; 1992 Jan; 18(1):67-80. PubMed ID: 1374195
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.